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Post-traumatic stress disorder (PTSD) currently has no FDA-approved treatments
that reduce symptoms in the majority of patients. The ability to extinguish fear
memory associations is impaired in PTSD individuals. As such, the development
of extinction-enhancing pharmacological agents to be used in combination with
exposure therapies may benefit the treatment of PTSD. Both mGlu5 and CB1
receptors have been implicated in contextual fear extinction. Thus, here we tested
the ability of the mGlu5 positive allosteric modulator 3-Cyano-N-(1,3-diphenyl-1Hpyrazol-5-yl)benzamide (CDPPB) and cannabidiol (CBD) to reduce both conditioned
and unconditioned fear. We used a predator-threat animal model of PTSD which we
and others have previously shown to capture the heterogeneity of anxiety responses
observed in humans exposed to trauma. Here, 1 week following a 10-min exposure
to predator scent stress, rats were classified into stress-Susceptible and stressResilient phenotypes using behavioral criteria for elevated plus maze and acoustic
startle response performance. Two weeks after classification, rats underwent 3 days
of contextual fear extinction and were treated with vehicle, CDPPB or CBD prior to each
session. Finally, the light-dark box test was employed to assess phenotypic differences
and the effects of CDPPB and CBD on unconditioned anxiety. CDPBB but not CBD,
reduced freezing in Susceptible rats relative to vehicle. In the light-dark box test for
unconditioned anxiety, CBD, but not CDPPB, reduced anxiety in Susceptible rats.
Resilient rats displayed reduced anxiety in the light-dark box relative to Susceptible
rats. Taken together, the present data indicate that enhancement of mGlu5 receptor
signaling in populations vulnerable to stress may serve to offset a resistance to fear
memory extinction without producing anxiogenic effects. Furthermore, in a susceptible
population, CBD attenuates unconditioned but not conditioned fear. Taken together,
these findings support the use of predator-threat stress exposure in combination with
stress-susceptibility phenotype classification as a model for examining the unique drug
response profiles and altered neuronal function that emerge as a consequence of the
heterogeneity of psychophysiological response to stress.
Keywords: fear extinction, TMT, resilient, mGlu5, mPFC, BLA, Fos
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and habituation in the acoustic startle response (ASR) 7 days
after PSS exposure. Control rats are placed into the PSS context
without predator odor and are later assessed in the EPM and ASR.
Most humans exposed to trauma initially display symptoms of
distress and anxiety which dissipate within 1–4 weeks following
the trauma (Foa et al., 2006). A similar pattern is observed in the
PSS model: 1 day following PSS exposure, approximately 90% of
PSS exposed rats are classified as Susceptible; by the 7th day postexposure, this rate drops to 25%, nicely paralleling the human
condition (Cohen et al., 2003). We and others have demonstrated
that in unstressed Control rats, the percent of rats classified
as Susceptible is much lower, at 1.33–4% (Cohen et al., 2003;
Schwendt et al., 2018). Thus, the anxiety phenotype in Susceptible
rats is induced by PSS exposure, and is not present in the absent
of such exposure.
Likewise, we have recently reported that a single 10min exposure to TMT gives rise to distinct stress-Susceptible
and Resilient phenotypes in Sprague-Dawley rats, with each
group presenting distinct behavioral, hormonal, and molecular
signatures (Schwendt et al., 2018). Notably, we found that
while all TMT-exposed rats and Control rats displayed similar
freezing during the PSS exposure, only Susceptible rats displayed
increased freezing upon re-exposure to the PSS context whereas
Resilient and Control rats did not. Furthermore, Susceptible rats
do not decrease freezing over the course of 5 days of extinction
exposures to the PSS context (Schwendt et al., 2018). Taken
together, these findings indicate phenotypic heterogeneity among
populations of stressed animals which may have an unseen
influence on the conclusions gained measuring fear extinction
within the entire population of stressed animals. Thus, studies
addressing differential vulnerabilities may reveal novel fearassociated adaptations.
In healthy humans, neuroimaging studies have revealed an
important role for neural activity in the circuitry encompassing
medial prefrontal cortex (mPFC) and amygdala during fear
extinction. Increased activity is observed in the ventral medial
prefrontal cortex (vmPFC) and decreased activity observed
in the dorsal lateral prefrontal cortex (dlPFC; Milad et al.,
2007) and amygdala (LaBar et al., 1998). Opposite patterns are
demonstrated in humans with PTSD, with low vmPFC activity
and high activity in both dlPFC and amygdala (Milad et al.,
2009). As noted above, the neural correlates of fear extinction
in rodents have been extensively studied using footshock
models, and suggest a conserved mechanism also involving
functional interactions between the mPFC and amygdala. In the
rodent mPFC, the prelimbic (PL) and infralimbic (IL) cortices
(analogous to the dlPFC and vmPFC in humans, respectively)
are strongly interconnected with the basolateral amygdala (BLA;
Hoover and Vertes, 2007). The BLA is required for extinction
of conditioned footshock (Falls et al., 1992), and serves to
regulate fear response through output to the central amygdala
(CeA) and brainstem regions (Royer et al., 1999; Haubensak
et al., 2010). Chemogenetic, or electrical stimulation of IL or PL
pathways targeting the BLA reveal opposing influences (Herry
et al., 2008; Senn et al., 2014), with IL enhancing, and PL
impairing extinction (Sierra-Mercado et al., 2011). Additionally,
inhibitory and excitatory IL and PL projections (respectively)

INTRODUCTION
Post-traumatic stress disorder (PTSD) develops in a subset
of individuals following a traumatic event (Perkonigg et al.,
2000). A characteristic feature of PTSD is impaired fear
memory extinction (Orr et al., 2000; Guthrie and Bryant, 2006),
which contributes to the persistent anxiety and hyperarousal
experienced by affected individuals (Herman, 1992; Norrholm
et al., 2011). Fear extinction is an active learning process where
stimuli that previously elicited fear are repeatedly presented in
the absence of threat to produce a gradual reduction in fear
response (Bouton et al., 2006). While extinction-based exposure
therapies are frequently used as a strategy for treating anxiety-like
disorders, PTSD-associated extinction deficits reduce the efficacy
of these treatments (Schottenbauer et al., 2008). Consequently,
there is a need to improve currently available therapies for
PTSD. One approach that directly addresses extinction deficits
in PTSD would involve the co-administration of extinctionenhancing pharmacological agents with exposure therapy to
improve treatment outcomes (e.g., Rothbaum et al., 2014).
Animal models are essential to interrogate the neurobiology
underlying fear extinction and for the development of novel
extinction-enhancing therapeutics. The most commonly used
models are grounded in Pavlovian fear conditioning principles
(Pavlov, 1927; Rescorla, 1988). Fear conditioning involves pairing
an unconditioned aversive stimulus (US; e.g., mild electric shock)
with neutral conditioned stimuli (CS; e.g., a discrete cue or
context) until a conditioned fear response (CR; e.g., freezing,
changes in heart rate) is produced following delivery of the CS
alone. Like exposure therapy, fear extinction training involves
prolonged, or repeated presentations of the CS alone, and ideally
results in the gradual elimination of the CR (Rothbaum and
Schwartz, 2002; Barad, 2005).
Footshock stress is commonly used to study fear learning,
and although these models have contributed substantially to
our understanding of neural circuits involved in conditioning
and extinction of fear, several alternatives to footshock have
been established, each offering unique and complementary
contributions to the field. Notably, inescapable exposure to
species-relevant predator odors (also termed as predator scent
stress, PSS) can evoke persistent alterations in behavioral and
physiological response in rats that mirror the symptom profile
of fear and anxiety related disorders such as PTSD. Exposure of
rodents to 2, 3, 5-Trimethyl-3-thiazoline (TMT), a synthetically
derived component of fox feces (Vernet-Maury et al., 1984)
induces hyperarousal (Hebb et al., 2003), anxiety (Rosen et al.,
2015), social dysfunction (Stockman and McCarthy, 2017),
vulnerability to substance use (Schwendt et al., 2018), and
contextually cued defensive behaviors (Fendt and Endres, 2008;
Homiack et al., 2017), indicating the incidence of both sensitized
and conditioned fear and anxiety like behaviors.
A key advantage of using PSS models is the ability to examine
physiological features associated with the individual differences
in vulnerability to such stress. As previously established for PSS
using cat odor (Cohen et al., 2003, 2014; Nalloor et al., 2011),
rats can be separated into Susceptible, Resilient and Intermediate
phenotypes based on scores in both the elevated plus maze (EPM)
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clinical usefulness. Several recent studies have demonstrated
that cannabidiol (CBD), a component of cannabis which lacks
THC-like psychoactive effects (Campos et al., 2012b), may serve
to mitigate symptoms of PTSD by increasing extinction and
reducing post-trauma anxiety in both humans and rodents
(Bitencourt et al., 2008; Das et al., 2013).
Here we evaluated the effects of CDPPB and CBD on the
extinction of contextual fear in a PSS model. We focused
our investigation on rats with stress-Susceptible phenotype, as
Resilient and Control rats do not demonstrate freezing upon reexposure to the conditioning context (Schwendt et al., 2018).
Further, this study explored possible changes in neuronal activity
(via Fos expression) produced by fear extinction training within
the PL, IL, and BLA regions. Given the involvement of PL, IL,
and BLA neuronal activity in extinction to conditioned footshock
(Cho et al., 2013), and evidence indicating an important role for
mGlu5 receptor function (Sethna and Wang, 2016), we predicted
that treatment with CDPPB would (a) enhance extinction of
contextual fear, and (b) increase Fos expression in all three
regions. Finally, this study also considered the effects of CDPPB
and CBD treatment on unconditioned anxiety, as anxiogenic
effects may compromise the utility of these drugs for fearextinction therapies.

regulate BLA excitability, stabilizing fear response inhibition
(Cho et al., 2013). This evidence suggests that extinction of
footshock conditioned fear requires a switch from PL- to ILmediated reciprocal signaling through the BLA. Indeed, the
assessment of neuronal activity using c-Fos immunoreactivity
reveals high Fos expression in the IL, but not PL following
extinction, and PL and BLA Fos expression correlating with
extinction resistance (Knapska and Maren, 2009). While TMT
exposure is also associated with changes in amygdala, IL, and
PL activity (Sevelinges et al., 2004; Hwa et al., 2019), and recent
studies implicate these regions in the extinction of conditioned
fear with alternative predator odors, how the coordinated activity
across these regions may contribute to the suppression of TMT
conditioned fear remains undetermined.
Glutamate receptor signaling has been the focus of many
efforts in the development of extinction-enhancing agents.
Metabotropic glutamate receptor 5 (mGlu5) subtype regulates
bidirectional synaptic plasticity in fear-associated brain regions
including the mPFC and BLA (Niswender and Conn, 2010).
Pharmacological and genetic inhibition of mGlu5 impairs
extinction of both cues and contexts paired with footshock (Xu
et al., 2009; Fontanez-Nuin et al., 2011; Sepulveda-Orengo et al.,
2013; Sethna and Wang, 2016), and administration of mGlu5
positive allosteric modulators (PAMs) enhances extinction of
a footshock-paired context (e.g., Sethna and Wang, 2014).
Although antagonism of mGlu5 receptors impairs consolidation
of extinction memory, these drugs have also been found to
produce anxiolytic effects (Porter et al., 2005; Rahman et al.,
2017). The consequences of glutamate receptor modulation on
the extinction of predator odor conditioned fear has been assesses
in only one study that demonstrated partial agonism of NMDA
receptors with D-cycloserine enhanced extinction of a cat odorpaired context (Sarıdoğan et al., 2015). We have previously
found increased mGlu5 gene expression in the amygdala and
mPFC of Resilient rats following re-exposure to the TMTassociated context (Schwendt et al., 2018). In the same study,
daily systemic treatment with the mGlu5 PAM CDPPB during
extinction of the TMT-paired context increased freezing in a
cohort of Susceptible rats that previously underwent cocaine
self-administration (Schwendt et al., 2018). However, as chronic
cocaine can alter both function and mGlu5 receptors numbers
in brain regions associated with fear signaling (Hao et al., 2010;
Ghasemzadeh et al., 2011; Schmidt et al., 2011), a primary goal
here was to examine the effects of CDPPB on fear extinction in
cocaine-naïve rats using this model.
Like mGlu5, CB1 receptors are abundantly expressed in the
BLA and mPFC and are important modulators of fear and anxiety
signaling (Chhatwal and Ressler, 2007). Previous studies have
revealed dysregulated expression of CB1 receptors and abnormal
levels endocannabinoids in subjects with PTSD (Neumeister
et al., 2015), as well as in rodent PTSD models (Schwendt
et al., 2018). In rodents, genetic or pharmacological inhibition
of CB1 receptors impairs extinction (Marsicano et al., 2002),
while CB1 agonists have extinction-enhancing effects (Chhatwal
et al., 2005; Campolongo et al., 2009). However, CB1 agonists can
also produce biphasic anxiogenic and anxiolytic effects (Haller
et al., 2004; Sink et al., 2010), which may compromise their
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MATERIALS AND METHODS
Animals
Adult male Sprague-Dawley rats (Charles River; N = 307)
were individually housed in ventilated cages in a vivarium
maintained on a 12:12 light-dark cycle (lights off at 7:00 am).
Prior to the beginning of the study, rats were acclimated to
the vivarium for 7 days with ad libitum access to food and
water. Beginning 72 h after arrival, rats were carefully handled
to become familiar with experimenters (always one male and
one female experimenter) prior to stress induction. Food access
was restricted to 20 g/day from the beginning of testing to
be consistent with our previous publication with this model
(Schwendt et al., 2018). All procedures were performed within
4 h of the beginning of the dark cycle. Rats arrived in 3 cohorts of
80–110 rats over the course of 1 year. Procedures were approved
by the Institutional Animal Care and Use Committee at the
University of Florida.

Drugs
3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB,
30 mg/kg; Abcam Biochemical) was suspended in 10% Tween
80 (Sigma-Aldrich) in phosphate-buffered saline (PBS) to a final
concentration of 30 mg/ml and injected subcutaneously (s.c.).
The dose of CDPPB was based on previous studies indicating an
effect on fear extinction (Sethna and Wang, 2014). Cannabidiol
(CBD, 5 mg/kg) was provided by the NIDA controlled substances
program (RTI, Research Triangle, NC) and dissolved in a mixture
of 100% ethanol, Cremophor, and 0.9% NaCl to 5 mg/ml and
injected intraperitoneally (i.p.). The dose of CBD was based on
previous studies demonstrating an effect on enhancing footshock
conditioned contextual fear conditioning (Jurkus et al., 2016),
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(four at a time) were secured in the plexiglass cylinders and
acclimated to the chamber for 5 min. Next, 30 pulses of 110 db
white noise were delivered for 40 ms followed by a variable (30–
45 s) intertrial interval. Startle habituation was calculated as the
percent change in startle amplitude from the first six trials to the
last six trials.

and is within a range of doses found to produce anxiolytic effects
(Guimarães et al., 1990). Locomotor testing was not performed
as given doses of CDPPB and CBD do not affect locomotion in
rats (Gass and Olive, 2009; Ren et al., 2009). 2, 3, 5-Trimethyl3-thiazoline (TMT, 5 µl; BioSRQ) was presented undiluted (97%
purity). The amount of TMT used for predator odor exposures
was based on previous studies by our laboratory and others
(Tanapat et al., 2001; Day et al., 2004; Schwendt et al., 2018).

Experiment 1 – The Effects of CDPPB of Contextual
Fear Extinction and Context-Induced Fos
Protein Expression
Fear extinction

Experimental Procedures
Predator-Scent Stress Exposure

The timeline for this experiment is shown in Figure 2A. Rats first
underwent predator stress induction and EPM/ASR assessment
(see above and Figure 1A). Rats classified as Susceptible
were randomly subdivided into two groups: Sus-Veh and SusCDPP (n = 7/group). Two weeks after anxiety assessment, rats
underwent three contextual fear extinction sessions on three
separate days. We previously found that in Susceptible rats with
a history of cocaine self-administration, treatment with CDPPB
immediately prior to placement into the TMT context increased
freezing on Days 2–4 of extinction (Schwendt et al., 2018). Here
we sacrificed rats immediately after Day 3 of extinction in order
to examine neuronal activity during the last extinction session.
Twenty minutes before sessions, rats were injected with either
vehicle or CDPPB and returned to their home cage. Rats were
then placed into the exposure chamber in the absence of TMT
for 10-min sessions (one session/day). To avoid potential residual
scent, we used plexiglass chambers which never had contact
with TMT. Sessions were filmed, and freezing was quantified
offline using the mobility detection function in Ethovision XT
14 software according to Pham et al. (2009). Freezing in rats is a
species-specific threat-related defensive strategy that is defined by
the absence of movement except for respiration (Fanselow, 1980).

The timeline for the predator-scent stress exposure and
assessment of anxiety is shown in Figure 1A. Six to 10 days after
arriving in the vivarium, rats received a single exposure to TMT
in a covered, clear cylindrical Plexiglas chamber (BioBubble Pets;
40 cm diameter × 35 cm height) with steel mesh flooring above a
clear plastic dish. Prior to each session, TMT (5 µl) was placed on
a square of filter paper positioned in the center of the dish. Rats
were individually placed in the test chamber for a single 10 min
exposure. Test chambers were cleaned with 70% ethanol between
sessions. Exposures were videotaped.
Power analyses (G power) indicated the number of animals
needed was 7–8/treatment group with a significance level of 0.05.
We have previously shown that the incidence of the Susceptible
phenotype amongst TMT-exposed rats ranges from 14 to 21.8%
(Schwendt et al., 2018). Thus, with a target of 8 rats/group for
a total of 16 Susceptible rats needed for Experiments 1 and 32
needed for Experiment 2, we initially exposed 307 rats to TMT.

Elevated Plus Maze (EPM)
Seven days after TMT exposure, all rats were tested on the
EPM according to previously described procedures (Pellow et al.,
1985). The EPM apparatus (Med Associates) was made from
black acrylic and consists of four arms (50 cm length × 10 cm
width) raised 50 cm from the floor. Two open arms (2.5 cm high
walls) and two closed arms (50 cm high walls) are joined by a
center square platform (10 cm × 10 cm) illuminated at 50 lux.
Rats were individually placed on the center platform facing a
closed arm and allowed to move freely for 5 min. Sessions were
filmed by a camera secured above the maze. The EPM was cleaned
with 70% ethanol between tests. Total time spent in the open arms
excluding time in the center area (OA time) was recorded with
EthoVision XT 14 software (Noldus Information Technology)
and served as a measure for anxiety.

Combined Fos immunohistochemistry and fluorescent
in situ hybridization
Next, we performed fluorescent immunolabeling for Fos protein
to measure neuronal activity during the third extinction session.
Fos is widely used relative marker for neuronal activation
(Lanahan and Worley, 1998; Kovács, 2008). As previous studies
have demonstrated a role for mGlu5 in the regulation of
cFos, and stimulation of mGlu5 with CDPPB can enhance
cFos expression (Mao and Wang, 2003; Mao et al., 2005;
Uslaner et al., 2009), we also performed dual-labeling for mGlu5
mRNA. Two hours after the third extinction session, rats were
administered an overdose of sodium pentobarbital (Euthasol,
1 ml, i.p.) and transcardially perfused in nuclease free 0.9%
NaCl followed by cold 4% paraformaldehyde (PFA) in PBS.
Brains were removed, post-fixed for 12 h at 4◦ C in 4% PFA
in PBS, cryopreserved in 30% sucrose in PBS, frozen and kept
at −80◦ C until sectioning. Twelve-µm-thick tissue sections
corresponding to the rat PL/IL (+3.00 mm relative to Bregma)
and BLA (−2.52 mm) according to rat brain atlas (Paxinos and
Watson, 2005), were collected using a freezing cryostat (Leica
CM1950). Tissue sections were direct-mounted onto Superfrost
Plus Gold slides (Fisher Scientific), dried, and stored at −80◦ C.
Fluorescent in situ hybridization of GRM5 (mGlu5) mRNA was

Acoustic Startle Response
Immediately after EPM testing, habituation of acoustic startle
response (ASR) was assessed according to Valsamis and Schmid
(2011). Four ventilated soundproof chambers (San Diego
Instruments) each contained a transparent plexiglass cylinder
that rested on a pressure-sensitive platform. An accelerometer
fitted to the platform measured changes in pressure created
from movement of the rat’s body, and the maximum response
amplitude was registered during presentation of acoustic stimuli.
Accelerometer calibration and acoustic sound levels were
routinely checked, and chambers were cleaned with CaviCide
disinfectant (Metrex) and 70% ethanol between sessions. Rats
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FIGURE 1 | Susceptible and Resilient rats display distinct behavioral phenotypes. (A) Timeline for behavioral classification. (B) Time spent in the open arms of the
EPM plotted against % habituation of acoustic startle response (ASR) for all TMT exposed rats (n = 299). Median splits performed on EPM open arm time
(median = 56.2 s) and % ASR habituation (median = 61.2%) were used to classify rats into Susceptible (Sus, n = 74), Resilient (Res, n = 74), or intermediate (Int,
n = 151) phenotypes. (C) Sus rats spent less time in the open arms of the EPM and (D) exhibited attenuated habituation to ASR relative to Res rats. ∗ p < 0.0001.

and 561 nm laser lines were used for excitation of DAPI,
Fos (Cy3), and mGlu5 (FITC). Two regions of interest were
selected for each brain area (PL, IL, and BLA; Figure 2D)
and Z-stacks were acquired at 1 µm intervals using a 63×
oil immersion objective. Image stacks were imported into NIH
Image J software (Schneider et al., 2012) and analyzed offline.
Only the middle five focal planes from each Z-stack were
used for analysis. To measure co-expression, Z-stacks were first
converted to composite images for separation of individual color
channels. The red channel (mGlu5) was then turned off, and
cells containing green (Fos) staining were marked using the NIH
Image J multi-point tool on each focal plane. Then, the green
channel was then turned off, and the red channel was used to
mark mGlu5 puncta in the same manner. Individual cells were
distinguished based on DAPI nuclei staining. Fos expression
was established if staining within a cell was detectable on three
consecutive focal planes, and mGlu5 expression was established if
a cell contained mRNA puncta on three consecutive focal planes.
Under these conditions, cells expressing both Fos and mGlu5
were considered positive for co-expression. The total number of
Fos expressing and Fos/mGlu5 co-expressing cells were counted
for each selected area. The average number of cells for each
parameter across the two selected areas was calculated for the
three brain regions for each rat.

performed using the RNAscope Multiplex Fluorescent Reagent
Kit (ACDBio) according to the manufacturer’s instructions with
a few modifications (Wang and Zhuo, 2012). Slides were first
equilibrated to room temperature (RT) before heating to 60◦ C
for 45 min. Next, sections were fixed in cold 4% PFA in PBS
and dehydrated using ethanol gradient of 50, 70, 100, and
100% in consecutive 5 min incubations. Slides were boiled in
target retrieval reagent (ACDbio), washed in nuclease-free H2 O,
and again dehydrated in 100% ethanol. Proteinase digestion
of sections was conducted using pretreatment #3 (ACDbio) at
40◦ C for 30 min under humidity-controlled conditions (HybEZ
hybridization oven; ACDbio). The RNAscope probe for GRM5
(ACDBio: 471241-C2, lot 17335A) was diluted with C1 diluent
probe (1:50) and applied to sections. Slides were then incubated
2 h at 40◦ C for hybridization of probe to target mRNAs. Signal
amplification was performed with preamplifier and amplifier
probes at 40◦ C (AMP 1, 30 min; AMP 2, 15 min; AMP
3, 30 min; AMP 4, 15 min). For AMP4 (15 min), Alt-A
was selected so that the target probe could be detected with
ATTO 550 (Cy3) fluorescent label. Immediately following in situ
hybridization, slides were rinsed three times in Tris-buffered
saline (TBS) and blocked (0.3% Triton x-100 and 5% NGS in
TBS) for 1 h at RT. TBS was used for all rinses and antibody
dilutions. Sections were incubated in rabbit anti-Fos antibody
(1:1000; Synaptic Systems) overnight at 4◦ C. The next day slides
were rinsed and then incubated in goat anti-rabbit Alexa 594
secondary antibody (1:1000; Invitrogen) for 2 h at RT. Finally,
sections were rinsed again before counterstaining with DAPI
(Invitrogen) and coverslipped using ProLong Gold antifade
mounting reagent (Invitrogen).

Experiment 2 – The Effects of CDPPB (or CBD) on
Unconditioned Anxiety and Contextual
Fear Extinction
The timeline for this experiment is shown in Figures 3A, 4A.
Rats first underwent predator stress induction and anxiety
assessment as described above. Susceptible rats were randomly
selected from the sample to create vehicle (Sus-Veh; n = 8),
CDPPB treated (Sus-CDPPB; n = 8), and CBD treated (SusCBD; n = 8) groups. Resilient rats were treated with vehicle
(Res-Veh; n = 8).

Imaging
Fluorescent images were captured using Zeiss LSM70 inverted
Axio-Observer 3-channel spectral confocal microscope and Zen
2012 software. Multitrack sequential imaging settings were
applied to avoid inter-channel crosstalk effects. The 405, 488,
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FIGURE 2 | CDPPB reduces context dependent freezing in Sus rats and increases Fos expression in the medial prefrontal cortex. (A) Timeline for Experiment 1.
(B) Treatment groups did not differ in EPM open arm time or % ASR habituation. (C) Mean ± SEM of freezing in vehicle (n = 7) or CDPPB (n = 7) treated Susc rats
during 10 min extinction sessions in the TMT context initiated 14 days after phenotype classification; CDPPB reduced freezing on day 2 of extinction. (D) Schematic
indicating the regions of interest (ROI) used for characterization of extinction dependent neuronal activity in the prefrontal cortex (top) and basal lateral amygdala
(BLA; bottom). (E) Representative confocal images from the selected ROIs in the prelimbic cortex (PL; left), infralimbic cortex (IL; middle) and BLA (right) showing
fluorescent immunolabeling of Fos (green) protein, labeling of mRNA for mGlu5 using fluorescent in situ hybridization, and DAPI (blue) nuclear staining, in vehicle (top
panel) and CDPPB (bottom panel) treated susceptible rats; scale bar: 20 µm, 63× magnification. Fos+mGlu5 co-expression is indicated with white arrows.
(F) CDPPB increased the number of Fos labeled cells in the PL and IL regions on day 3 of extinction. (G) The effects of CDPPB on the number of Fos+/mGlu5+
double-labeled cells in the PL, IL, and BLA on day 3 of extinction. ∗ p < 0.05, ∗∗ p < 0.01 relative to vehicle, # p < 0.05 relative to Days 1 and 3.

300 lux, and a dark compartment (dark box) with blackened
opaque walls. An opening in the dividing wall allowed free
movement of rats between the compartments. Prior to testing,
rats were treated with vehicle, CDPPB, or CBD in their home
cage. Following pretreatment (CDPPB: 20 min; CBD: 30 min),
each animal was individually placed in the center of the light
box and allowed to roam freely for 10 min. Sessions were

Light-dark box
Two weeks after anxiety assessment and phenotype classification,
rats underwent light-dark box testing based on previously
described procedures (Crawley, 1981). Light-dark box apparatus
consisted of a plexiglass box with two separate compartments
of equal dimensions (40 cm × 44 cm × 37 cm); a light
compartment (light box) with translucent walls illuminated at
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FIGURE 3 | Cannabidiol attenuates increased anxiety-like behavior in the light-dark box test in Susceptible rats. (A) Timeline for Experiment 2. (B) Vehicle (Sus-veh,
n = 8), CDPPB (Sus-CDPPB), and CBD (Sus-CBD, n = 8) treated Sus rats spent less time in the open arms of the EPM and (C) exhibited reduced habituation to
ASR relative to vehicle treated Res rats (Res-veh, n = 8). (D) CBD treated Sus rats and Res rats spent less time in the dark-box relative to vehicle treated Sus rats.
(E) CBD treatment reduced the latency to enter the light-box in Sus rats. (F) No differences were observed in latency to enter the dark-box. ∗∗ p < 0.05 relative to
Res-veh; ∗ p < 0.05 relative to Sus-veh.

to test for within region differences in Fos expression between
treatment groups. One-way analyses of variance (ANOVAs)
were used to assess differences in EPM and ASR behavior
for rats later treated with vehicle, CBD or CDPPB to ensure
no pre-existing differences prior to initiation of testing and
pharmacological treatment. Freezing during fear extinction was
analyzed by two-way mixed factorial repeated-measures (RM)
ANOVAs with Treatment as the between-subjects factor and
Day as a within-subjects factor. Significant interactions were
followed by Tukey’s post hoc analyses with corrections for
multiple comparisons.

filmed, and the following behaviors were hand scored by an
experimenter blind to the conditions: (1) latency to enter the
dark box from the light box and vice versa; (2) the number
of transitions between compartments; and (3) the duration of
individual compartment visits. The apparatus was cleaned with
70% ethanol between trials.

Fear extinction
Next, rats were used to assess differences between Resilient and
Susceptible rats in fear extinction and the ability of CBD to
enhance the extinction of TMT conditioned fear. The day after
light-dark box testing, rats were administered vehicle or CBD
20 min prior to testing (Figure 4A). Rats received the identical
treatment that they had received on the day prior for lightdark box testing. Procedures for fear extinction were identical
to Experiment 1.

RESULTS
Predator Odor Stress and
Susceptibility Classification

Data Analysis

A total of 307 rats were exposed to TMT. ASR data files for
8 rats were corrupted and thus the following calculations are
based on the data from 299 rats. The median time spent in
the OA of the EPM was 56.2 s and median habituation of the
ASR was 61.2%. Rats that fell below the median for time spent

GraphPad Prism (version 6.0) was used for statistical analysis
with the alpha level set at p ≤ 0.05. Unpaired t-tests were used
to compare phenotypic differences in EPM and ASR behavior for
rats used in Experiments 1–2. Unpaired t-tests were also used
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FIGURE 4 | Cannabidiol does not reduce increased context dependent freezing in Susceptible rats. (A) Timeline for Experiment 2. (B) Mean ± SEM of freezing in
vehicle (Sus-veh; n = 8) and CBD (Sus-CBD; n = 8) treated Sus rats and vehicle treated Res rats (Res-veh; n = 7) during 10 min extinction sessions. A main effect of
Group was detected with Sus-veh and Sus-CBD displaying increased freezing relative to Res-veh rats.

observed on Days 1 or 3. Within the Sus-veh group, Day 2
freezing was greater than Days 1 and 3 (Figure 2C). Analysis
of Fos immunoreactive cells revealed increased Fos expression
in the PL [t(10) = 2.80, p = 0.02], IL [t(10) = 3.03, p = 0.01] of
Sus-CDPPB rats compared to Sus-veh (Figure 2F). In the BLA,
a trend toward increased Fos protein expression was detected
in Sus-CDPPB group (p = 0.054). Co-expression of Fos and
mGlu5 was abundant across analyzed regions of both treatment
groups, however, the level of Fos/mGlu5 expression overlap
varied between regions (Sus-veh, [F(2,15) = 2.756, p = 0.0125];
Sus-CDPPB [F(2,15) = 0.830, p < 0.0001]), with lower coexpression in the BLA (∼70%) compared to both IL and PL
regions (∼90%; data not shown). Perhaps due to this high degree
of co-localization, CDPPB treatment increased Fos expression
in mGlu5-positive cells in a manner that was similar to overall
Fos expression: expression was increased in the PL [t(10) = 2.92,
p = 0.04] and IL [t(10) = 3.30, p = 0.01], but not in the BLA
(Figure 2G). Representative images of dual Fos/mGlu5 labeling
from the regions depicted in Figure 2D are shown in Figure 2E.

in the OA and above the median for ASR habituation were
classified as Susceptible as in our previous report (Schwendt
et al., 2018). Rats were classified as Resilient if they fell above the
median for time spent in the OA and below the median for ASR
habituation. This resulted in 74 rats (25%) meeting criteria for the
Susceptible phenotype and an equal number meeting criteria for
the Resilient phenotype (Figure 1B). A total of 46 Susceptible rats
and 8 Resilient rats were used for the present set of experiments.
More Susceptible and Resilient rats were generated than were
needed for the present set of experiments and were used for other
experiments to be published at a later date. Rats not classified
as either Susceptible or Resilient (Intermediate; n = 151) were
eliminated from the experiment. Susceptible (Sus) rats spent less
time in the open arms of the EPM [t(26) = 4.482, p < 0.0001,
Figure 1C], and exhibited less reductions in ASR magnitude
[t(26) = 4.515, p < 0.0001, Figure 1D] compared to Resilient rats.
Freezing was assessed on the day of TMT exposure in a subset of
Susceptible (n = 20) and Resilient (n = 20) rats; no phenotypic
differences in freezing were found (mean ± SEM: Susceptible
10.2 ± 2.438 s; Resilient 10.8 ± 2.624 s).

Experiment 2
Experiment 1

Subsets of Susceptible (Sus) and Resilient (Res) rats were used to
generate four treatment groups: Sus-veh, Sus-CDPPB, Sus-CBD,
and Res-vehicle. Examining only the rats utilized for Experiment
2, a one-way ANOVA revealed phenotypic differences in EPM
open arm time [F(3,27) = 37.61, p < 0.0001, Figure 3B] and
ASR habituation [F(3,27) = 8.028, p = 0.0006]. All three groups
of Sus rats spent less time compared to Res rats in the open arms
of the EPM (Sus-veh, p < 0.0001; Sus-CDPPB, p < 0.0001; SusCBD, p < 0.0001, Figure 3B), and exhibited less habituation of
the ASR relative to Res rats (Sus-veh, p = 0.0023; Sus-CDPPB,
p = 0.0023; Sus-CBD, p = 0.0029, Figure 3C). In the light-dark
box test, Group differences in time spent in the dark side were

Rats were assigned to receive vehicle (Sus-vehicle, n = 7) or
CDPPB (30 mg/kg, s.c.; Sus-CDPPB, n = 7) prior to extinction
sessions such that there were no differences in prior EPM and
ASR scores between treatment groups (Figure 2B). To examine
the effects of CDPPB on fear extinction, a 2-way RM ANOVA
conducted on freezing behavior (Figure 2C) revealed a main
effect of Treatment [F(1,11) = 6.803, p = 0.024] and Day
[F(2,22) = 3.905, p = 0.035], and a significant Treatment × Day
interaction [F(2,22) = 5.134, p = 0.015]. Post hoc tests revealed
that on Day 2, Sus-CDPPB rats froze significantly less than Susveh rats, and no between-group differences in behavior were
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found [F(3,27) = 4.686, p = 0.0092, Figure 3D]. Post hoc analysis
revealed Sus-veh rats spent more time in the dark side compared
to Res-veh, indicating the preservation of anxiety phenotypes
2 weeks after classification with EPM and ASR. In Susceptible
rats, CDPPB did not alter time spent in the dark (p = 0.692,
Sus-CDPPB vs. Sus-veh), however, CBD had an anxiolytic effect,
demonstrated by a reduction in dark box time (p = 0.023, SusCDB vs. Sus-veh). Time spent in the dark in Sus-CBD rats did
not differ from Res-veh rats. One-way ANOVA also revealed
differences in latency to enter the light box [F(3,25) = 3.315,
p = 0.036, Figure 3E], with CDPPB again having no effect, and
CBD reducing the time to enter relative to the Sus-veh treated
group. No phenotypic or treatment differences were observed in
the latency to enter the dark side (Figure 3F).
On the day following the light-dark box test, rats began fear
extinction trials that continued for 3 days. Prior to each trial
animals received CBD (5 mg/kg, i.p.) or vehicle. A two-way
repeated measures ANOVA on time spent freezing revealed a
significant main effect of group [F(2,20) = 4.106, p = 0.032]
and a trend toward a significant group × time interaction
[F(4,40) = 2.197, p = 0.08]. There was no main effect of time
[F(2,40) = 0.2389, n.s.] (Figure 4B).

(Wallace and Rosen, 2000; McGregor et al., 2002; Blanchard et al.,
2003), hence any conditioning effects may have been obscured.
Consistent with our previous report, we observed an increase
in freezing in vehicle-treated Susceptible rats from Day 1 of
extinction to Day 2 (Schwendt et al., 2018). CDPPB treated
rats demonstrated less freezing on the 2nd day of re-exposure
compared to vehicle rats. One potential interpretation of these
data is that vehicle-treated rats experienced a potentiation
of fear memory reconsolidation on Day 1 that resulted in
greater freezing on Day 2; CDPPB prevented this fear memory
reconsolidation, yielding reduced freezing. Alternatively, CDPPB
treatment may have aided in extinction memory consolidation
on Day 1 by enhancing mGlu5 receptor activity within extinction
associated neuronal pathways, manifesting as a decrease in
freezing on Day 2. As freezing decreased in vehicle-treated rats
from Days 2 to 3, these rats may have engaged in extinction
acquisition and consolidation during day 2 which was exhibited
on Day 3. Extinction of conditioned fear cannot be said to
have occurred in the CDPPB-treated group, as no differences in
freezing were observed in this group across days, potentially due
to a floor effect on freezing on Day 1. Assessment of freezing
in CDPPB-treated rats on a subsequent “recall” test conducted
in the absence of CDPPB would potentially have shed some
light on whether CDPPB is acting acutely to enhance extinction
or fear; however, we had designed the present experiment to
assess Fos expression on Day 3. Thus, future work will aim
to understand whether CDPPB is reducing freezing through
the acquisition, consolidation, or expression of fear extinction
behavior by administering CDPPB in different regimens, such
as immediately after the re-exposure session or only on Day
1 of extinction.
A reduction in conditioned fear in CDPPB-treated rats is in
contrast to our previous report that this dose of CDPPB increases
freezing when administered prior to fear extinction in rats with
a history of cocaine self-administration. It can be argued that
chronic self-administration of cocaine altered the neurobiology
underlying the extinction of conditioned fear. Alternatively,
previous studies in rats and humans have demonstrated bi-phasic
effects of the NMDA receptor partial agonist D-cycloserine,
which can either produce a weakening or a strengthening of
fear memory contingent upon an individual’s experience during
the extinction session (Orr et al., 2000; Bolkan and Lattal,
2014). Furthermore, in cocaine users, D-cycloserine prevents the
reductions in craving and brain activation produced by extinction
of cocaine-associated cues. Taken together, this suggests that
cocaine alters the role of glutamate receptors in mediating
extinction of both fear and cocaine-associated cues (Price et al.,
2013; Prisciandaro et al., 2013). This should be considered in
the treatment of anxiety disorders in patients with cocaine
use disorder.
A substantial literature devoted to understanding signaling
dynamics involved in the extinction of footshock conditioned
fear indicates implicates roles of the IL and PL. Indeed, many
studies examining expression of neuronal activity markers in
these regions have correlated activity in the PL with freezing, and
IL activity with reductions in freezing during extinction (Herry
et al., 2008; Cho et al., 2013; Senn et al., 2014). Here we found

DISCUSSION
Here we found that 7 days after a single exposure to the predator
odor TMT, populations of stress Susceptible and Resilient rats
emerged following phenotype classification using EPM and ASR
scores. Similar to previous studies (e.g., Cohen and Zohar,
2004), including our own (Schwendt et al., 2018), 25% of
rats met criteria for the Susceptible phenotype and an equal
number met criteria for the Resilient phenotype. Moreover, we
found that a majority of rats displayed EPM and ASR behavior
intermediate between Susceptible and Resilient rats, suggesting
that the two phenotypes were indeed representative of extremes
of the susceptibility spectrum. In the current study, light-dark
box testing 2 weeks after the initial classification revealed that
un-conditioned anxiety also differs between Susceptible and
Resilient phenotypes.
Consistent with our previous report (Schwendt et al., 2018),
the results of Experiment 2 indicate that 3 weeks following
the initial TMT context pairing, conditioned fear in Susceptible
rats was greater than in Resilient rats. While some previous
studies failed to produce a conditioned fear response with TMT
(McGregor et al., 2002; Blanchard et al., 2003; Rosen, 2004),
these studies only tested for such a response 24 h after TMT
exposure. We hypothesize that conditioned freezing in the TMTpaired context here and in our previous report (Schwendt
et al., 2018) may be due to the inclusion of a post-stress
incubation period. A lengthier exposure time in a medium
size chamber may also have contributed to an accumulation
of contextual CS information sufficient to generate a defensive
response upon re-entry to the TMT-paired context; exposures in
smaller chambers do not have this effect (Takahashi et al., 2008).
Furthermore, past studies examining TMT fear conditioning
have not distinguished stress-Susceptible rodents from Resilient
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fear extinction through its involvement in synaptic plasticity
(Heifets and Castillo, 2009), and dysregulated eCB signaling
has been implicated in PTSD (Neumeister et al., 2013). In
addition, CBD can function as a partial agonist of the 5HT1a receptor (Russo et al., 2005; Campos et al., 2012a;
Fogaça et al., 2014). Abnormal 5-HT signaling contributes to
PTSD like symptoms (Zhao et al., 2017), and is a target for
treatment of the disorder (Sullivan and Neria, 2009). Thus,
further study is needed to more exhaustively characterize the
potential of CBD in PTSD treatment. While CBD did not enhance
extinction, it was effective in reducing anxiety in the lightdark box test. Our findings are consistent with previous work
showing benefits of CBD in alleviating heightened anxiety in
animals that have experienced prior footshock or restraint-stress
(O’Brien et al., 2013; Fogaça et al., 2014; Song et al., 2016).
While chronic CBD administration following exposure to a live
predator was effective in mitigating predator-induced anxiety
1 week later (Campos et al., 2012a), we are the first to show an
immediate effect of CBD in a population of Susceptible rats after
only a single dose.

increased Fos activation in CDPPB-treated rats in the absence of
significant decreases in freezing on the day that the tissue was
collected. It is possible that although extinction may have been
occurring in both treatment groups on Day 3, the timing of tissue
collection did not permit the assessments of the temporal patterns
of PL and IL activity during the session. For instance, we cannot
determine whether a brief fear recall event at the beginning of
Day 3 extinction produced a depolarization of PL cells which
may no longer have been firing near the end of the session.
Analysis of Fos+mGlu5 co-expression revealed that the increased
Fos expression was most likely a result of CDPPB binding, due to
the fact that (a) very few Fos-positive cells did not contain mGlu5
mRNA, and (b) increased Fos expression in mGlu5-positive cells
mirrored overall Fos protein increase. Thus, it is possible that
the increase in Fos expression is an artifact of CDPPB that is not
related to freezing behavior or extinction. It may also possible be
the case that CDPPB treatment affected non-extinction associated
mGlu5 containing cells. In order to understand the role of this
circuitry in contextual fear extinction in Susceptible rats, future
work will infuse mGlu5-targeting drugs directly into the mPFC
and BLA prior to or after fear extinction sessions.
While mGlu5 receptors represent a promising target for
reducing conditioned fear, mGlu5 agonists can produce
anxiogenic effects under certain conditions (De Jesús-Burgos
et al., 2016; Rahman et al., 2017). Therefore, we evaluated the
ability of CDPBB to alter unconditioned fear in the light-dark
box. We found that CDPPB neither attenuated nor enhanced
anxiety in the light-dark box task. This is in contrast to a recent
report that the same dose of CDPPB increased anxiety measures
in the light-dark box in unstressed mice and in mice that had
consumed alcohol (Lee et al., 2018). Thus, CDDPB or other
mGlu5 PAMs may be beneficial in a PTSD population as they
would reduce conditioned fear without inducing general anxiety,
but caution should be exerted in alcohol users.
Although prior studies in heterogeneous rodent populations
have observed extinction enhancing properties of CBD in a
conditioned footshock model (Bitencourt et al., 2008; Stern
et al., 2012; Do Monte et al., 2013), here there was no effect of
CBD on conditioned fear in Susceptible rats. It is possible that
TMT exposure was not sufficient to evoke the neuroadaptations
necessary for CBD-mediated effects. Indeed, one recent study
demonstrated that while CBD enhanced extinction in footshock
conditioned rats, extinction was unaffected by CBD in rats
administered a reduced number of shocks (Song et al.,
2016). Although the dose of CBD used in the current study
(5 mg/kg) has been previously demonstrated as effective in
mitigating the response to contextually conditioned fear (e.g.,
Jurkus et al., 2016), this dose is at the lower end of an
inverted U-shaped response curve for extinction-enhancing
effects, which ranges from 3 to 30 mg/kg (Stern et al., 2012).
Here, we utilized a lower dose because higher doses of CBD
can also produce anxiogenic effects (Song et al., 2016; Lee
et al., 2017). The mechanisms by which CBD exerts proextinction and anti-anxiety effects are multifaceted, however,
several studies have demonstrated a capacity for indirect
potentiation of CB1 receptors (Bisogno et al., 2001; Campos
et al., 2013). Endocannabinoid (eCB) signaling is implicated in

Frontiers in Behavioral Neuroscience | www.frontiersin.org

CONCLUSION
Here we found evidence that mGlu5 PAMs, such as CDPPB,
represent a potential treatment strategy for the reduction of
conditioned fear in a PTSD population, an effect possibly
mediated by an activation of the PL/IL circuitry. However, some
preclinical work (Lee et al., 2018; Schwendt et al., 2018) suggests
that caution should be exerted when using this class of drugs in
patients with a history of cocaine or alcohol use, as it may inhibit,
rather than facilitate extinction. Finally, while CBD produced
anxiolytic effects in response to unconditioned fear, it failed
to enhance the extinction of conditioned fear in a Susceptible,
PTSD-like population of rats. As our results indicate distinct roles
for these drugs in unconditioned vs. conditioned anxiety, future
consideration should be given to polytherapy with both CBD and
mGlu5 PAMs for the enhancement of extinction and relief of
anxiety that accompany PTSD. For example, the combination of
CBD and an mGlu5 PAM such as CDPPB should be administered
for the assessment of unconditioned and conditioned fear.
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